SOME DISEASES CAUSED BY FILAMENTOUS FUNGI

1
SOME DISEASES CAUSED BY FILAMENTOUS FUNGI

• Chromoblastomycosis
• Mycetoma
• Mucormycosis
• Aspergillosis

2
CHROMOBLASTOMYCOSIS

• A chronic localized infection of the subcutaneous
  tissue caused by several species of dematiaceous
  fungi

3
Chromoblastomycosis

• Fonsecaea pedrosoi
• Fonsecaea compactum
• Phialophora verrucossum

4
Ecological AssociationChromoblastomycosis

• Soil
• Decaying vegetation

5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
Sclerotic Bodies

• A fungus form resulting from host defenses

10
SCLEROTIC BODIES
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
Chromoblastomycosis

• Melanin may be a virulence factor

15
Geographic distribution

• World-wide

16
CLINICAL SPECIMENS

• PUS
• BIOPSY MATERIAL

17
TREATMENT

• EXCISION
• TERBINEFINE
• ITRACONAZOLE

18
No Serological Tests Available
19
(No Transcript)
20
Mycetoma

• Tumefaction
• Granules
• Draining sinus tracts

21
(No Transcript)
22
Maduromycosis

• Madurella mycetomatis
• Phialophora jeanselmei
• Pseudallescheria boydii

23
GEOGRAPHIC DISTRIBUTION

• WARM CLIMATES
• (SE United States, South America, Africa)

24
ECOLOGICAL ASSOCIATION

• SOIL

25
Clinical SpecimensMycetoma

• Pus
• Tissue

26
DEMATIACEOUS HYPHAE
De
27
IDENTIFICATION

• Colonial morphology
• Conidia formation
• Granules
• Color
• Size shape
• Texture
• Biochemical reactions

28
Serological TestPseudalescheria

• Immunodiffusion

29
Therapy

• Terbinefine
• Itraconazole

30
(No Transcript)
31
Mucormycosis

• An acute infection characterized by inflammation
  and vascular invasion and thrombosis.

32
Mucormycosis

• Rhizopus species
• Mucor species
• Absidia species.

33
GEOGRAPHIC DISTRIBUTION

• WORLDWIDE

34
ECOLOGICAL NICHE

• UBIQUITOUS
• FOOD
• SOIL
• ORGANIC DEBRIS

35
UNCONTROLLED DIABETIC

• Rapidly fatal

36
MUCORMYCOSIS

• CLINICAL SIGNS
• Ketoacidosis
• Nasal stuffiness
• Proptosis
• Eschar

37
CHARACTERISITICS OF MUCOR INFECTION

• AFFINITY FOR ARTERIAL INVASION
• NASAL OR SINUS INFECTIONS
• DIRECT EXTENSION TO THE BRAIN THROUGH CRIBIFORM
  PLATE
• RAPIDLY FATAL

38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41
WIDE, NON-SEPTATE, RIBBON-LIKE
42
(No Transcript)
43
TREATMENT

• MUCORMYCOSIS
• Control diabetes
• Biopsy
• Culture
• Surgery (Debridement)
• Amphotericin B

44
SEROLOGIC TEST

• IMMUNODIFFUSION

45
(No Transcript)
46
ASPERGILLOSIS

• A variety of diseases
• Pulmonary, external ear, eyes, meninges, sinuses
  or blood stream

47
ECOLOGICAL ASSOCIATION

• UBIQUITOUS
• SOIL
• DECAYING VEGETATION
• FOOD
• MEDICATION
• AIR VENTS
• DISINFECTANTS

48
CLINICAL TYPES OF PULMONARY DISEASE

• ALLERGIC
• FUNGUS BALL
• INVASIVE

49
Difficult to diagnose

• Clinical symptoms are not specific
• Radiography not specific
• Blood cultures seldom positive
• Serology seldom positive (early)
• Invasive procedures for early detection

50
GEOGRAPHIC DISTRIBUTION

• WORLD-WIDE

51
COMMON PATHOGENIC SPECIES

• A. FUMIGATUS
• A. NIGER
• A. FLAVUS

52
(No Transcript)
53
HISTOPATHOLOGY

• DICHOTOMOUS BRANCHING
• SEPTATE HYPHAE

54
(No Transcript)
55
DICHOTOMOUS BRANCHING
56
(No Transcript)
57
(No Transcript)
58
SEROLOGIC TESTS

• IMMUNODIFFUSION
• (BANDS)
• GALACTOMANNAN
• (EIA)

59
DRUG OF CHOICE

• VORICONAZOLE
• AMPHOTERICIN B

60
(No Transcript)
61
DIMORPHIC FUNGI(Endemic Mycoses)

• SYTEMIC INFECTIONS
• LIMITED GEOGRAPHIC DISTRIBUTION
• SPECIFIC ECOLOGICAL NICHE
• MORPHOLOGICALLY DISTINCT

62
BLASTOMYCOSIS

• Blastomyces dermatitidis

63
BLASTOMYCOSIS

• A CHRONIC SUPPURATIVE AND GRANULOMATOUS DISEASE
  OF ANY TISSUE WITH A PREDILECTION FOR LUNGS,
  SKIN, PROSTATE AND BONE.

64
CLINICAL FORMS

• SYSTEMIC
• USUALLY PULMONARY
• CUTANEOUS
• PRIMARY
• SECONDARY

65
(No Transcript)
66
Pulmonary Symptoms

• Anorexia
• Weight loss
• Cough
• Night sweats

67
(No Transcript)
68
CLINICAL SPECIMENS

• SPUTUM
• PUS
• BIOPSY MATERIAL
• URINE

69
ECOLOGICAL ASSOCIATION

• ORGANIC DEBRIS
• (SOIL, ROTTED WOOD, DECAYED VEGETATION)

70
(No Transcript)
71
(No Transcript)
72
(No Transcript)
73
Virulence Factor

• BAD1

74
(No Transcript)
75
(No Transcript)
76
(No Transcript)
77
(No Transcript)
78
(No Transcript)
79
(No Transcript)
80
(No Transcript)
81
Wet Mount
82
SEROLOGIC TEST

• IMMUNODIFFUSION
• COMPLEMENT FIXATION
• EIA

83
DRUGS OF CHOICE

• ITRACONAZOLE
• AMPHOTERICIN B
• VORICONAZOLE

84
(No Transcript)
85
(No Transcript)
86
(No Transcript)
87
END